Mandate

VGC Partners invests MSEK 52.5 in Sproud International AB

VGC Partners I LP (”VGC”) has invested MSEK 52.5 in a directed share issue in Sproud International AB ("Sproud"), in order to finance Sproud’s continued expansion of its range of sustainable pea-based products under the trademark Sproud, as an alternative to dairy products.

VGC is a London-based venture capital fund focused on providing growth capital to innovative early-stage consumer, media and tech companies.

Vinge represented VGC in the fundraising, with Jesper Ottergren as lead partner.

 

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025